Teva Pharmaceutical Industries TEVA
NYSE TEVA
$36.92 -0.55 (-1.47%)
At close: Aug 20, 2026 · 1:49 PM UTC

Teva Pharmaceutical Industries (TEVA) EPS (Basic) Growth (3y) (2012 - 2026)

Teva Pharmaceutical Industries (TEVA) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn 15.17%
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 3.18%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 2.42%
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn 12.25%
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn -35.06%
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 13.47%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 36.60%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn -86.99%

Historic Data

Download Data
DateValue
Jun 30, 2026 15.17%
Mar 31, 2026 50.53%
Dec 31, 2025 32.79%
Sep 30, 2025 86.99%
Jun 30, 2025 43.87%
Mar 31, 2025 30.45%
Dec 31, 2024 -21.07%
Sep 30, 2024 -48.13%
Jun 30, 2024 -82.33%
Mar 31, 2024 83.65%
Dec 31, 2023 -139.38%
Sep 30, 2023 26.35%
Jun 30, 2023 -102.79%
Mar 31, 2023 -77.52%
Dec 31, 2022 -140.55%
Sep 30, 2022 30.07%
Jun 30, 2022 26.51%
Mar 31, 2022 -108.96%
Dec 31, 2021 99.64%
Sep 30, 2021 44.78%